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Interventional Neuroradiology: Henry Ford Hospital Experience 
with Ttanscatheter Embolization of Vascular Lesions in the Head, 
Neck, and Spine 
Bharat A. Mehta, MD,* Clifford R. Jack, Jr, MD,* Roushdy S. Boulos, MD, PhD,' 
Suresh C. Patel, MD,* James I. Ausman, MD, PhD,^  and Ghaus M. Malik, MD^  
Innovative developments over the past 15 years have resulted in increased sophistication and 
effectiveness of therapeutic neuroembolization procedures. As a result, percutaneous transcatheter 
embolization has assumed an increasingly important role in the management of patients with vascular 
lesions of the head, neck, and spine. By reducing bleeding during surgery, this technique can 
markedly facilitate the surgical approach to difficult vascular lesions. The technique may also be 
applied in cases where surgery is contraindicated. 
Therapeutic neuroembolization has been performed in 23 patients with vascular lesions of the head, 
neck, or spine at Henry Ford Hospital. Devascularization ofthe extraaxial blood supply was achieved 
in all cases, and no neurologic complications were encountered. Eighteen patients with vascular 
tumors ofthe head, neck, or spine and three patients with arteriovenous malformations (AVM) were 
embolized preoperatively, resulting in markedfacilitation ofthe surgical procedures. One patient with 
a dural AVM and one with a spinal metastasis were embolized without surgery. (Henry Ford Hosp Med 
J 1986;34:19-30) 
Transcatheter embolization procedures have assumed an in-creasingly important role in the management of vascular le-
sions ofthe head, neck, and spine in recent years. A variety of 
innovative developments over the past 25 years have fueled the 
rapid development of neuroembolization techniques. 
In the 1960s, Luessenhop (1) pioneered the injection of si-
lastic spheres into the intemal carotid artery (ICA) to embolize 
intracranial arteriovenous malformations (AVM). Embolization 
of the exti-aaxial blood supply of head, neck, and spine lesions 
was reported by several groups in the early 1970s (2,3). New 
vascular occlusive agents directed primarily at the extraaxial 
blood supply of head and neck vascular lesions as well as 
vascular spinal cord lesions were developed in the late 1970s 
and early 1980s. These include microspheres, autologous 
clot, Gelfoam, polyvinyl alcohol sponge (PVA), collagen, 
lypophihzed dura, and liquid polymers (3-7). 
Improvements in catheter delivery system technology as well 
as a more fliorough understanding of both the vascular anatomy 
and the pathophysiology of head, neck, and spine lesions have 
resulted in the increasingly wide applicability of neuroem-
bolization procedures (3,7-11). The development of digital sub-
traction angiography (DSA) in the 1970s and the cunent wide-
spread availability of this technology represents a significant 
step forward. 
Neuroembolization therapy is a rapidly changing field with 
many areas of active research. Modem ti-eatment of many vas-
cular lesions of the head, neck, and spine crosses many medical 
disciplines. This necessitates close communication between the 
referring clinician, neuroradiologist, and various specialists, 
particularly the neurosurgeon, otolaryngologist, neurologist, 
plastic surgeon, radiation therapist, and oncologist. It is impor-
tant for clinicians to be aware of developments in this field be-
cause select patients serve to benefit greatiy from the application 
of these techniques. 
This paper discusses only the neuroembolization procedures 
performed at Henry Ford Hospital. Our nonembolization inter-
ventional neuroradiologic procedures are discussed in a separate 
paper (12). Goals, risks, and techniques for effective neuroem-
bolization are also discussed. 
Patients, Methods, and Results 
Embolization technique 
Technical considerations in therapeutic embolization of vas-
cular tumors and AVMs are nearly identical. A diagnostic an-
giogram must be obtained before consideration of a therapeutic 
embolization procedure. The angiogram is reviewed, and a spe-
cific therapeutic approach is developed by the team of spe-
cialists, including the neuroangiographer, caring for the patient. 
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The patient is admitted to the hospital the evening before the 
therapeutic embolic procedure. At that time the neuroangio-
grapher wUl outline for the patient and family the technical 
considerations of the procedure, the risks, benefits, and goals. 
Fig 1(A)—A 60-year-old woman with a large left frontal 
meningioma; Computed tomography (CT) scan. 
The therapeutic procedure is performed with the parient 
awake, under mild sedation and mild analgesia. The procedure 
is done by introducing a thin-walled nontapered angiographic 
catheter, usually via the transfemoral approach, into branches of 
the extemal carotid artery (ECA). Beginning with the largest, 
the individual arterial branches supplying the lesion are super-
selectively catheterized, then embolized. Embolization is per-
formed by careful hand injection of a slurry, which is a mixture 
of embolic particles, heparinized saline, and x-ray contrast ma-
terial. The injection is done under fluoroscopic monitoring to 
prevent reflux ofthe sluny into proximal arteries supplying nor-
mal tissue. The ideal end point is defined by obliteration of the 
abnormal capillary vascular stain in the lesion while preserving 
flie integrity of the main feeding arteries. Frequent test (DSA) 
rans are obtained to evaluate the approach to the end point. 
Case material and results 
Twenty-three patients have undergone neuroembolization 
procedures at Henry Ford Hospital from 1981 through 1985. AU 
procedures were performed by one of the authors (Mehta) in the 
Department of Radiology, Division of Neuroradiology. These 
23 patients can be conveniently grouped into four categories 
based on the therapeutic goal of the interventional procedure and 
the underlying pathology. 
Preoperative tumor embolization—Eighteen patients under-
went preoperative particulate embolization for devascularization 
of head, neck, and spine tumors. Patients' ages ranged from 5 to 
74. 
Tumor blood supply derived from external carotid artery 
branches was successfully embolized in five patients with me-
ningioma (Fig 1), one with a temporal malignant fibrous 
histiocytoma, and one with a gliosarcoma (Fig 2). The arterial 
Fig 1(B)—A 60-year-old woman with a large left frontal 
meningioma; Preembolization left external carotid artery 
injection late venous phase demonstrating diffuse tumor stain 
(arrow). 
Fig 1(C)—A 60-year-old woman with a large left frontal 
meningioma; Postembolization left external carotid artery 
injection demonstrating obliteration ofthe tumor vascular stain 
with preservation ofthe main external carotid arterial trunks. 
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supply (intercostal arterial branches) to a metastatic hyper-
nephroma involving the T3 vertebral body was also successfully 
embolized (Fig 3). 
Embolization was successfully performed in five patients 
with juvenile nasopharyngeal angiofibroma (Fig 4), three with 
glomus tympanicum (Fig 5), one with glomus jugulare, and one 
with a carotid body tumor 
A sluny of Gelfoam particles (UpJohn, Kalamazoo, MI) was 
the embolic agent used in all 18 cases. Devascularization of the 
extraaxial blood supply to the tumor was achieved in all cases 
and no neurologic complications were encountered. All patients 
had surgery within 24 hours. In all 18 cases, preoperative tumor 
devascularization decreased blood loss during surgery and en-
abled the surgeon to achieve a more complete and less compli-
cated tumor resection. 
Tumor embolization without surgery—A patient with a single 
tumor was treated with embolization and radiation therapy with-
out surgery. This elderly man had a highly aggressive metastatic 
hypernephroma to the osseous structures comprising the cra-
niocervical junction. This unresectable metastasis had rapidly 
destroyed the Cl vertebral body, part of C2, and the foramen 
magnum, which resulted in marked craniovertebral instabUity. 
Each ofthe three ECA branches feeding the tumor mass was su-
perselectively catheterized by femoral approach and injected 
with 1 mL of dehydrated ethyl alcohol (Abbott Laboratories, 
Chicago, IL) (Fig 6). This resulted in complete ablation of tumor 
vascularity and immediate pain control without neurologic com-
plication. The patient eventually died of unrelated problems. 
Preoperative arteriovenous malformation embolization— 
The extraaxial blood supply was embolized preoperatively in 
three patients with head and neck arteriovenous malformations, 
without neurologic complication. Embolization resulted in fa-
cUitation of the ultimate surgical resection in each case. 
A 29-year-old man had a facial AVM, a cirsoid aneurysm of 
the scalp, involving the forehead, with both ECA and 
ophthalmic artery supply. The ECA supply was successfully 
embolized with polyvinyl alcohol sponge (PVA) (Unipoint Ind., 
Highpoint, NC). This resulted in immediate and marked im-
provement in what had been a significant cosmetic facial defor-
mity (Fig 7). 
A 34-year-old woman had recent intracranial hemonhage and 
dense left hemiparesis from a known high-flow right frontal 
AVM. This huge AVM had both intraaxial and exti-aaxial sup-
ply. The latter arose from branches of the external carotid ar-
teries bilaterally. The ECA branches supplying the AVM were 
embolized bilaterally with PVA, resulting in reduced ECA flow 
and facilitation of the AVM resection (Fig 8). 
A 48-year-old woman had a sudden onset of right hemiplegia 
and aphasia due to intracerebral hemonhage. Angiography re-
vealed a dural AVM along the left tentorial leaf which drained 
into the vein of Galen. The ECA branches were embolized with 
several Giantro coils (Cook, Bloomington, IN), which resulted 
in facilitation of surgical resection. 
i l 
Fig 2(A)—A 55-year-old woman with a left frontotemporal 
gliosarcoma; CT scan. 
Fig 2(B)—A 55-year-old woman with a left frontotemporal 
gliosarcoma. Lateral view; preembolization left external 
carotid artery injection shows extraaxial tumor supply (arrow). 
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Fig 2(C)—A 55-year-old woman with a left frontotemporal 
gliosarcoma. Lateral view;postembolization left external 
carotid injection demonstrating patient's main external carotid 
artery trunks with obliteration ofthe tumor vascular stain. 
Arteriovenous malformation embolization without surgery— 
A single AVM patient was treated with embolization alone with-
out surgery. She had a subjectively intolerable intracranial brait 
due to a large dural AVM of the right transverse sinus and was 
deemed a nonsurgical candidate due to advanced age (85) and 
the extensiveness of the lesion. Embolization without surgery 
was felt to be the safest therapeutic altemative for this patient. 
The ECA branches supplying this lesion were embolized with 
PVA, which resulted in nearly complete but temporary an-
giographic occlusion and cessation of symptoms. The symp-
toms, however, recuned at 48 hours, and the patient refused fur-
ther angiography which would have provided an understanding 
ofthe recunent symptoms and treatment options. No neurologic 
complication was encountered (Fig 9). 
Discussion 
In recent years, percutaneous transcatheter embolization has 
played an increasingly important role in the management of 
AVMs and vascular tumors of the head, neck, and spine (2-4,9). 
The goals, risks, and technique of embolizing vascular head, 
neck, and spine tumors are essentially identical to those for em-
bolizing AVMs. 
Anatomic considerations 
The normal blood supply of head and neck stmcmres is cate-
gorized as either intraaxial, extraaxial, or both. Intraaxial sup-
ply consists of intemal carotid artery (ICA) and basilar artery 
branches which supply brain parenchyma. Extraaxial supply 
Fig 3(A)—Postmetrizamide myelogram CT in a 58-year-old 
man with metastatic hypernephroma to the right side ofthe T3 
vertebral body (larger arrow) with partial effacement ofthe 
metrizamide fllled subarachnoid space (smaller arrow). 
Fig 3(B)—Preembolization injection ofthe right supreme 
intercostal artery demonstrating tumor vascular stain (arrow). 
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consists of extemal carotid artery (ECA) branches and specific 
small branches of the ICA and vertebral artery which supply 
nonbrain tissue, eg, skin, bone, dura, etc. (13). The extraaxial 
blood supply of head and neck lesions can be embolized without 
damage to neurologic tissue. 
In the spine, branches of the intercostal arteries (radic-
ulomedullary branches) which supply normal spinal cord 
tissue (most notably the artery of Adamkiewicz) should not be 
embolized. The arterial supply to bone and paraspinal soft tissue 
can be embolized. 
The most important guideline in all embolization procedures 
is to achieve selective deposition of particulate embolic material 
in abnormal tissue while sparing normal tissue (13). This is par-
ticularly critical in head, neck, and spine embolization pro-
cedures where accidental embolization of the central nervous 
system could cause a devastating neurologic deficit. Knowledge 
of primary and collateral vascular pathways to the brain, cranial 
nerves, and spinal cord is essential. 
A " X 
Fig 3(C)—Postembolization injection of the right supreme 
intercostal demonstrating obliteration of tumor vascular stain. 
Fig 4(A)—CT scan of a 14-year-old boy with a large right-sided 
juvenile nasopharyngeal angioflbroma (arrow). 
Eig 4(B)—Preembolization. Lateral view right external carotid 
injection showing intense tumor vascular stain. 
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Fig 4(C)—Postembolization injection showing tumor 
devascularization. 
Fig 5(A)—A 56-year-old man with a right-sided glomus 
tympanicum. Preembolization; lateral view right common 
carotid injection showing obliteration of tumor vascular stain 
(arrow). 
Fig 5(B)—A 56-year-old man with a right-sided glomus 
tympanicum. Postembolization; lateral view right common 
carotid injection shewing obliteration of tumor vascular stain 
(arrow). 
Eig 6(A)—Postmetrizamide myelogram CT of a 78-year-old 
man with metastatic hypernephroma destroying the body ofthe 
CI vertebral body (arrow). 
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Fig 6(B)—Lateral view; preembolization right common carotid 
artery injection showing obliteration of tumor vascular stain 
involving Cl vertebral body and surrounding soft tissues. 
Eig 6(C)—Lateral view; postembolization right common 
carotid artery injection showing obliteration of tumor vascular 
stain involving CI vertebral body and surrounding soft tissues. 
r 
Fig 7(A)—A 29-year-old man with a facial AVM of the scalp. 
Lateral view; preembolization left external carotid injection 
arterial phase showing arterial supply from ECA branches as 
well as the AVM nidus (arrow). 
Fig 7(B)—A 29-year-old man with a facial AVM of the scalp. 
Venous phase of Fig 7(A) injection lateral film showing large 
scalp vein draining the AVM (arrow). 
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Fig 7(C)—A 29-year-old man with a facial AVM of the scalp. 
Postembolization; lateral view. Left external carotid injection 
showing obliteration ofthe ECA supply to the AVM. 
Fig 8(A)—A 34-year-old woman with a huge right frontal AVM 
with both intraaxial and extraaxial supply. Lateral view; right 
ICA injection showing intraaxial supply to AVM. 
Fig 7(D)—A 29-year-old man with a facial AVM of the scalp. 
Postembolization; lateral view. Left internal carotid injection 
showing residual ICA AVM supply from the ophthalmic artery 
which could not be embolized. 
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Fig 8(B)—A 34-year-old woman with a huge right frontal AVM 
with both intraaxial and extraaxial supply. Preembolization 
left selective middle meningeal artery injection showing 
obliteration ofthis extraaxial feeder. 
Transcatheter Embolization—Mehla el al 
Fig 8(C)—A 34-year-old woman with a huge right frontal AVM 
with both intraaxial and extraaxial supply. Postembolization left 
selective middle meningeal artery injection showing 
obliteration ofthis extraaxial feeder. 
Fig 8(E)—A 34-year-old woman with a huge right frontal AVM 
with both intraaxial and extraaxial supply. Postembolization left 
selective superficial temporal artery. 
Fig 8(D)—A 34-year-old woman with a huge right frontal AVM 
with both intraaxial and extraaxial .supply. Preembolization left 
selective superficial temporal artery. 
Fig 9(A)—An 85-year-old woman with a large inoperable dural 
AVM ofthe right transverse sinus. Postembolization; lateral 
view. Selective right MMA injection showing devascularization 
ofthe arterial rete (arrow) which had supplied the AVM nidus. 
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Eig 9(B)—An 85-year-old woman with a large inoperable dural 
AVM of the right transverse sinus. Preembolization; selective 
percutaneous needle (smaller arrow) puncture of the right 
occipital artery (larger arrow) from which a rete of small 
arterial feeders supply the dural AVM nidus (hollow arrow). 
Goals 
Tumor embolization—The goal of preoperative embolization 
of head, neck, and spine tumors is tumor devascularization. Se-
lective deposition of embolic material within the capillary bed of 
a tumor can promote thrombosis within the tumor vascular bed. 
This greatly facilitates surgical resection primarily by decreas-
ing bleeding during surgery. In addition to devascularization, 
preoperative embolization may shrink the tumor In many cases 
preoperative embolization may make complete or more com-
plete tumor resection possible (2,8,13). Hospital stays are short-
ened and the need for transfusion and its attendant risks are 
diminished. Preoperative embolization is helpful in patients 
who refuse transfusion for personal or religious reasons. This 
beneficial aspect of preoperative embolization may become in-
creasingly important if concern about the safety of random do-
nor blood product transfusion continues to increase. To prevent 
revascularization of tumors from adjacent collateral sources, as 
would occur with AVMs, surgery should be performed after tu-
mor embolization whenever possible. 
Embolization can be an essential part of a combined (with 
chemotherapy and postembolization radiation therapy) pal-
liative therapeutic approach to unresectable tumors. De-
vascularization by embolization has been shown to inhibit tumor 
growth and aid pain control (2,14,15). 
AVM embolization—A variety of therapeutic approaches to 
head and neck AVMs have been reported (surgery alone, radia-
tion therapy, injection of sclerosing agents, and systemic 
steroids) (9). Surgical resection of facial AVMs is often tech-
nically difficult. Current controversy centers on whether sur-
gery alone, embolization alone, or a combined approach will 
yield the best results. 
The goal of preoperative AVM embolization as well as embo-
lotherapy without surgery is lesion devascularization. The pa-
thology in an AVM lies at the capillary level where abnormal 
arterial-to-venous shunting channels exist. To devascularize an 
AVM, occlusive embolic material must be deposited at the cap-
illary level. This is done by injecting emboli into the abnormal 
feeding artery and letting the flow cany emboli to the abnormal 
shunt site where it will lodge and result in progressive occlusion 
of shunt channels (2,3,11,13). 
Risks 
Damage to nonnal neurologic tissue due to inadvertent embo-
lization is the most serious risk associated with head, neck, and 
spine embolization procedures. Three different mechanisms 
may give rise to neurologic deficit during embolization: 
1. Reflux of embolic material from the ECA around the ca-
rotid bifurcation into the ICA circulation. This can be avoided 
by using a slow hand injection technique (under fluoroscopic 
guidance) so as not to elevate the pressure in the ECA vessel 
being embolized (13). The risk of reflux increases as the end 
point is approached due to increasing stasis in the artery being 
embolized (8). Liberal use of DSA test rans to carefully monitor 
approach to the end point also will reduce the possibility of 
reflux. 
2. Passage of embolic material through normally present 
extraaxial to intraaxial collateral channels may also produce 
stroke. An example of this type of normal communication is 
anastomoses between the occipital and vertebral artery at the Cl 
level. Knowledge of the anastomotic pathways and careful atten-
tion to their possible presence on the preembolization an-
giogram is a must. Superselective placement of the catheter tip 
beyond these communications will greatly reduce the risk of 
stroke by this means (13,16). 
3. The blood supply to the extracranial portions of most cra-
nial nerves is derived from ECA branches. Palsy of the 2nd and 
3rd division ofthe trigeminal nerve and cranial nerve 7 has been 
reported following embolization of the middle meningeal artery 
(MMA). Palsy of cranial nerves 3, 4, 6, and 5 (first division) 
have been reported following embolization of normal variants of 
the MMA. Embolization of the neuromeningeal branch of the 
ascending pharyngeal artery can result in cranial nerve 7, 9, 10, 
11, and 12 palsy (8,17). These cranial nerve palsies nearly always 
resolve in less than one year. A positive test injection of lido-
caine into the artery to be embolized prior to embolization wUl 
alert the neuroangiographer to this potential complication. 
Skin necrosis has been reported when too forceful an in-
jection of fine particulate embolic material is employed (13). 
Complications which are seen in most cases include postem-
bolization fever and local pain. These are easily treated with pre-
procedural and postprocedural steroids and analgesics. The 
symptoms nearly always resolve within days. 
Technical considerations 
Technical procedures are frequently long and tiring for both 
the angiographer and patient and may require several sittings be-
fore ideal results are achieved. The use of DSA has proved to be 
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an incalculable asset during these procedures. By providing in-
stant angiographic feedback with subti-action, DSA greatly de-
creases the length of the procedure, the attendant's discomfort, 
and fatigue of both patient and angiographer. DSA also has 
made possible the practice of multiple test rans during the pro-
cedure for meticulous monitoring of progress toward end pxiint. 
Prior to the availability of DSA, this practice while desirable 
from a safety standpoint was not realistic. 
A wide variety of embolic agents have been made available in 
recent years. Particulate embolizations reported herein were per-
formed with one of two compounds, either Gelfoam or PVA. 
Gelfoam is a temporary vascular occlusive agent. The material 
is degraded by proteolytic enzymatic pathways. The dissolution 
of the intravascular thrombus it produces begins 24 hours after 
embolization (6). Therefore, this material is used only for pre-
operative embolization. For optimum hemostatic effect, surgery 
should be performed within 24 hours of embolization (6). The 
key advantage of this material is ease of handling. Due to low 
viscosity, a Gelfoam sluny will flow smoothly through the 
caflieter, allowing conti-olled physiologic embolization (6,13). 
An additional advantage is that normal vessels inadvertently em-
bolized will eventually recanalize due to the temporary nature of 
this occlusive material. 
Conversely, PVA is a permanent occlusive agent. PVA parti-
cles serve as a "scaffolding" which promotes the ingrowth of 
fibroblasts (5,6). This fibroblastic proliferation results in perma-
nent vascular occlusion, with PVA an "integral" part of the 
body (5,6,18). PVA is used if surgery is not planned immedi-
ately or at all. The disadvantage of PVA is that it is more difficult 
to handle. A sluny of PVA particles is very viscous (5,6). There-
fore, it is difficult to achieve a smooth, controlled introduction 
through the catheter and the risk of inadvertent embolization of 
normal vessels is higher Also, accidental embolization of nor-
mal vessels will be permanent. 
Transcatheter embolization of an unresectable metastasis to 
the craniocervical region was performed with ethanol in one pa-
tient. Ethanol has been shown in animal studies to be an excel-
lent neurovascular sclerosing agent. When perfused directly into 
the middle cerebral artery of monkeys, focal segmental vascular 
sclerosis is produced with no distal endothelial injury and no 
seizure activity (19). Ethanol fulfills all the requirements ofan 
ideal vascular occlusive agent: low viscosity, nonadhesive, inex-
pensive, readily available, and easy to sterilize (19). 
Ethanol has been proven effective in human use for ablation 
of renal cell carcinoma (14). Used in this setting, it produces 
complete tumor necrosis and permanent arterial occlusion. This 
was the effect desired in the patient with end stage metastatic 
disease to the craniocervical junction. The mechanism of action 
appears to be direct cellular damage to the endothelium which is 
followed later by thrombosis (14,15). 
The one dural AVM embolized with intravascular coils was 
performed early in our embolization experience. This technique 
results in arterial occlusion proximal to the AVM nidus and 
would not be our method of choice today (13). 
Much remains unknown in the field of therapeutic neuroem-
bolization. Initial vascular occlusion postembolization depends 
on a variety of factors including particle size, thrombogenicity 
of embolic material, the method of injection (selectively and 
control of blood flow), and hemodynamic characteristics of the 
lesion to be embolized. The precise interrelationship of these 
variables wanants further study (3,6,13). Littie is known about 
embolization dynamics. The status of the embolized vascular 
bed changes flu-oughout an embolization procedure. The rela-
tive roles of vessel spasm, thrombosis, and histologic reaction of 
the vessel wall in producing vascular occlusion need to be evalu-
ated (3,6,13). 
Summary 
Therapeutic embolization techniques can be applied to a vari-
ety of vascular lesions of the head, neck, and spine. Our experi-
ence with these procedures has been summarized in four broad 
categories: preoperative tumor embolization, tumor emboliza-
tion without surgery, preoperative arteriovenous malformation 
embolization, and arteriovenous malformation embolization 
without surgery. With careful attention to technique, these pro-
cedures can be performed with minimal risk and with excellent 
therapeutic results. This is a rapidly changing field with many 
areas of active research. A broad range of clinical specialists 
should be aware of these techniques, as potential embolization 
candidates may be seen in many different clinical specialty 
areas. 
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